The evolution of Industry 4.0 capacities across regions in EU research programmes
Science and Public Policy · 26.03.2025 · 52 (2) · 269-283
DOI: 10.1093/scipol/scae077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science and Public Policy, online erschienen am 14.12.2024. Verfasst von Andrea Ciffolilli und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 104 Literaturangaben.
Abstract (Originalsprache)
European policy supports cutting-edge research on Industry 4.0, aiming to promote excellence and ensure a balanced distribution of regional Industry 4.0 capacities. We analyse Industry 4.0 research projects financed by the European Union’s framework programmes over a 14-year period, investigating whether less developed regions benefit from interaction with more advanced regions that have a stronger capacity to diversify their Industry 4.0 technologies. We find a strong path-dependency in technological diversification between programming periods. Moreover, while national Industry 4.0 programmes negatively affect the capacity of regions to diversify technologies, possibly generating a substitution effect, we find that regional networking does not support less diversified regions in mastering multiple technologies.
Zitieren
APA
Ciffolilli, A., Lopolito, A., Muscio, A., & Reid, A. (2025). The evolution of Industry 4.0 capacities across regions in EU research programmes. Science and Public Policy, 52(2), 269-283. https://doi.org/10.1093/scipol/scae077
Vancouver
Ciffolilli A, Lopolito A, Muscio A, Reid A. The evolution of Industry 4.0 capacities across regions in EU research programmes. Science and Public Policy. 2025;52(2):269-283. doi:10.1093/scipol/scae077
BibTeX
@article{Ciffolilli2025,
author = {Ciffolilli, Andrea and Lopolito, Antonio and Muscio, Alessandro and Reid, Alasdair},
title = {The evolution of Industry 4.0 capacities across regions in EU research programmes},
journal = {Science and Public Policy},
year = {2025},
volume = {52},
number = {2},
pages = {269--283},
doi = {10.1093/scipol/scae077}
}
EUVIMED